Michael F. Price’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | – | Sell |
-103,910
| Closed | -$715K | – | 126 |
|
2019
Q3 | $715K | Sell |
103,910
-965
| -0.9% | -$6.64K | 0.1% | 89 |
|
2019
Q2 | $968K | Hold |
104,875
| – | – | 0.13% | 86 |
|
2019
Q1 | $1.64M | Hold |
104,875
| – | – | 0.2% | 74 |
|
2018
Q4 | $1.62M | Hold |
104,875
| – | – | 0.22% | 74 |
|
2018
Q3 | $2.26M | Hold |
104,875
| – | – | 0.28% | 65 |
|
2018
Q2 | $2.55M | Hold |
104,875
| – | – | 0.3% | 63 |
|
2018
Q1 | $1.79M | Hold |
104,875
| – | – | 0.21% | 75 |
|
2017
Q4 | $1.99M | Buy |
104,875
+50,000
| +91% | +$947K | 0.25% | 72 |
|
2017
Q3 | $966K | Sell |
54,875
-665,125
| -92% | -$11.7M | 0.13% | 80 |
|
2017
Q2 | $23.9M | Hold |
720,000
| – | – | 3.1% | 8 |
|
2017
Q1 | $23.1M | Buy |
720,000
+23,500
| +3% | +$754K | 2.86% | 8 |
|
2016
Q4 | $25.2M | Buy |
696,500
+227,200
| +48% | +$8.24M | 3.06% | 7 |
|
2016
Q3 | $21.6M | Buy |
469,300
+29,000
| +7% | +$1.33M | 2.87% | 7 |
|
2016
Q2 | $22.1M | Hold |
440,300
| – | – | 2.94% | 7 |
|
2016
Q1 | $23.6M | Hold |
440,300
| – | – | 3.31% | 6 |
|
2015
Q4 | $28.9M | Hold |
440,300
| – | – | 3.56% | 6 |
|
2015
Q3 | $24.9M | Hold |
440,300
| – | – | 3.72% | 5 |
|
2015
Q2 | $26M | Hold |
440,300
| – | – | 3.42% | 7 |
|
2015
Q1 | $27.4M | Sell |
440,300
-7,200
| -2% | -$449K | 3.63% | 7 |
|
2014
Q4 | $25.7M | Sell |
447,500
-52,500
| -11% | -$3.02M | 3.14% | 9 |
|
2014
Q3 | $26.9M | Hold |
500,000
| – | – | 3.35% | 7 |
|
2014
Q2 | $26.2M | Buy |
500,000
+111,600
| +29% | +$5.85M | 3.21% | 6 |
|
2014
Q1 | $20.5M | Sell |
388,400
-11,600
| -3% | -$613K | 2.5% | 12 |
|
2013
Q4 | $16M | Buy |
400,000
+50,000
| +14% | +$2M | 2.07% | 22 |
|
2013
Q3 | $13.2M | Hold |
350,000
| – | – | 1.76% | 22 |
|
2013
Q2 | $13.7M | Buy |
+350,000
| New | +$13.7M | 1.84% | 21 |
|